Orsay, France

Guillaume Reveillon

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guillaume Reveillon. Retrieved from https://idiyas.com/inventor/guillaume-reveillon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Guillaume Reveillon

Introduction

Guillaume Reveillon is a notable inventor based in Orsay, France. He has made significant contributions to the field of imaging agents, particularly through his innovative patent. His work is recognized for its potential impact on pharmaceutical compositions.

Latest Patents

Guillaume Reveillon holds a patent titled "Imaging agents, process for the preparation thereof and pharmaceutical compositions containing same." This patent involves compounds of formula (I), where R is a linear or branched (C-C) alkyl, L is a spacer group, A is a diagnostic agent, and m is equal to 1 or 2. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Reveillon is affiliated with the Centre National de la Recherche Scientifique, a prestigious research institution in France. His role there allows him to engage in cutting-edge research and development, contributing to advancements in medical imaging and diagnostics.

Collaborations

Throughout his career, Guillaume has collaborated with esteemed colleagues such as Alain Lepape and Stéphanie Lerondel. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Guillaume Reveillon's work in the field of imaging agents exemplifies the importance of innovation in medical research. His contributions continue to pave the way for advancements in pharmaceutical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…